Porto Alegre

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis1 trial
• Kidney cancer1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Bristol-Myers Squibb2 trials

Running trials

• Not yet recruiting

  Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

  NCT07441408· Phase 3· Bristol-Myers Squibb· Source

  Contact: Site 0028

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Idiopathic pulmonary fibrosis1 recruiting

Closed trials

• Completed

  A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

  NCT04540705· Phase 1· Bristol-Myers Squibb· Source